The Clinical Tumor Lysis Syndrome in a Patient with Mixed Phenotype Acute Leukemia Undergoing Induction with Venetoclax and Azacitidine: A Case Report.

导出 LinkOut

翻译打印收藏纠错

作者： Joanna,Drozd-Sokolowska ^[1] ; Krzysztof,Mądry ^[1] ; Kinga,Siewiorek ^[1] ; Magdalena,Feliksbrot-Bratosiewicz ^[1] ; Tomasz,Stokłosa ^[2] ; Beata,Gierej ^[3] ; Agnieszka,Stefaniak ^[4] ; Małgorzata,Paszkowska-Kowalewska ^[1] ; Jacek,Sokołowski ^[5] ; Bartłomiej,Sankowski ^[2] ; Grzegorz Władysław,Basak ^[1]

作者单位： Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland. ^[1] Department of Immunology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland. ^[2] Department of Pathomorphology, Medical University of Warsaw, Warsaw, Poland. ^[3] Cytogenetics Laboratory, Public Pediatric Teaching Hospital in Warsaw, Warsaw, Poland. ^[4] Department of Otolaryngology, Medical University of Warsaw, Warsaw, Poland. ^[5]

关键词 Azacitidine Induction Mixed phenotype acute leukemia Tumor lysis syndrome Venetoclax

主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);阿扎胞苷(Azacitidine);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);表型(Phenotype);磺胺类(Sulfonamides);肿瘤溶解综合征(Tumor Lysis Syndrome)

DOI 10.1159/000524182

PMID 35325891

发布时间 2022-08-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交